Proto-Oncogene proteins c-mos

Preferred Label : Proto-Oncogene proteins c-mos;

MeSH definition : Cellular proteins encoded by the c-mos genes (GENES, MOS). They function in the cell cycle to maintain MATURATION PROMOTING FACTOR in the active state and have protein-serine/threonine kinase activity. Oncogenic transformation can take place when c-mos proteins are expressed at the wrong time.;

MeSH synonym : c mos proteins; c-mos, pp39; c-mos proteins; c-mos, proto-oncogene products; c-mos, proto-oncogene proteins; cytostatic factor; mos proto oncogene product pp39; mos proto oncogene proteins; mos proto-oncogene product pp39; mos proto-oncogene proteins; pp39(c-mos); products c-mos, proto-oncogene; proteins, c-mos; proteins c-mos, proto-oncogene; proteins, mos proto-oncogene; proteins mos, proto-oncogene; proto oncogene products c mos; proto-oncogene products c-mos; proto-oncogene proteins, mos; proto-oncogene proteins mos; proto oncogene proteins mos; pp39 c-mos; pp39 c mos; proto oncogene proteins c mos;

CISMeF synonym : EC 2.7.1.37;

Registry Number MeSH : EC 2.7.11.1;

MeSH annotation : /drug eff /ultrastruct permitted; DF: note short X refs;

Is substance : O;

UNII : EC 2.7.11.1;

Details

Origin ID

D017231;

UMLS CUI

C0072454;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- 5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha-2 [NCIt concept]
- Aurora Kinase C [NCIt concept]
- Cell Division Cycle 7-Related Protein Kinase [NCIt concept]
- Cyclin-Dependent Kinase 10 [NCIt concept]
- Cyclin-Dependent Kinase 2 [NCIt concept]
- Cyclin-Dependent Kinase 3 [NCIt concept]
- Leucine-Rich Repeat Serine/Threonine-Protein Kinase 2 [NCIt concept]
- MAP Kinase-Interacting Serine/Threonine-Protein Kinase 1 [NCIt concept]
- MAP Kinase-Interacting Serine/Threonine-Protein Kinase 2 [NCIt concept]
- Mitotic Checkpoint Serine/Threonine-Protein Kinase BUB1 Beta [NCIt concept]
- Nik-Related Protein Kinase [NCIt concept]
- Serine/Threonine-Protein Kinase 33 [NCIt concept]
- Serine/Threonine-Protein Kinase Nek10 [NCIt concept]
- Transcription Initiation Factor TFIID Subunit 1 [NCIt concept]
Indexing information
- FBXO43 protein, Xenopus [MeSH Supplementary Concept]
Record concept(s)
- Proto-Oncogene proteins c-mos [MeSH concept]
Related MeSH Supplementary Concept(s)
- mos protein, xenopus [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients